- Home
- ESS vs WAT Comparison
ESS vs WAT Comparison
Compare ESS & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESS
- WAT
- Stock Information
- Founded
- ESS 1971
- WAT 1958
- Country
- ESS United States
- WAT United States
- Employees
- ESS N/A
- WAT N/A
- Industry
- ESS Real Estate Investment Trusts
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- ESS Real Estate
- WAT Industrials
- Exchange
- ESS Nasdaq
- WAT Nasdaq
- Market Cap
- ESS 18.3B
- WAT 20.1B
- IPO Year
- ESS 1994
- WAT 1995
- Fundamental
- Price
- ESS $284.32
- WAT $342.65
- Analyst Decision
- ESS Hold
- WAT Buy
- Analyst Count
- ESS 19
- WAT 15
- Target Price
- ESS $309.00
- WAT $387.60
- AVG Volume (30 Days)
- ESS 464.2K
- WAT 424.4K
- Earning Date
- ESS 07-29-2025
- WAT 07-30-2025
- Dividend Yield
- ESS 3.60%
- WAT N/A
- EPS Growth
- ESS 27.78
- WAT 8.23
- EPS
- ESS 10.45
- WAT 11.02
- Revenue
- ESS $1,861,154,000.00
- WAT $2,983,253,000.00
- Revenue This Year
- ESS $3.69
- WAT $6.07
- Revenue Next Year
- ESS $3.86
- WAT $6.44
- P/E Ratio
- ESS $27.36
- WAT $31.07
- Revenue Growth
- ESS 9.74
- WAT 2.57
- 52 Week Low
- ESS $243.85
- WAT $279.24
- 52 Week High
- ESS $317.73
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- ESS 51.61
- WAT 46.54
- Support Level
- ESS $282.03
- WAT $334.00
- Resistance Level
- ESS $290.00
- WAT $349.91
- Average True Range (ATR)
- ESS 5.63
- WAT 8.05
- MACD
- ESS 0.20
- WAT -1.13
- Stochastic Oscillator
- ESS 58.48
- WAT 38.09
About ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 257 apartment communities with over 62,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.